CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in KROS — Keros Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,698,218
-$288,452 QoQ
Shares Held
158,712
-11.8% QoQ
Ownership
0.800%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. KROS ranks #194 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in KROS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,698,218 | 158,712 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,986,670 | 179,952 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,802,820 | 186,779 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,619,534 | 292,006 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,783,430 | 283,403 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,465,195 | 241,923 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $4,427,366 | 279,682 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $15,105,168 | 260,120 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,402,599 | 227,628 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $13,753,579 | 207,758 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $7,219,541 | 181,578 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,641,261 | 176,953 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,938,001 | 147,785 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,669,193 | 132,768 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,403,563 | 133,352 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,594,003 | 122,116 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,823,095 | 102,175 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,478,241 | 100,740 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,753,639 | 98,336 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,898,400 | 98,544 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,337,462 | 78,584 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,588,980 | 58,310 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,931,405 | 55,733 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,691,255 | 43,849 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,628,196 | 43,407 | Shares | Sole | 2020-08-20 | |
| No filing history on record for this holder in this stock. | ||||||